Long-term follow-up of patients with high myopia
Official title: Long Term Follow-up of Eyes With High Myopia
Run by Istituto Auxologico Italiano · NCT06322433 · Data updated 2026-11-12
This study looks at how high myopia changes over time in patients by tracking their eye health and imaging results for at least five years without any treatments.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 138 (estimated) |
| Sponsor | Istituto Auxologico Italiano Academic / other |
| Locations | 1 site (Milan) |
| Status | Recruiting |
| Started | November 1, 2023 |
| Main results expected | December 31, 2025 |
| Study ends | December 31, 2025 |
| Registry record updated | May 1, 2025 |
| Trial ID | NCT06322433 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are individuals diagnosed with high myopia.
✕Probably not a fit
Patients with acute ischemic optic neuropathy, macular and peripapillary atrophy, or other forms of maculopathy may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to assess the long-term evolution of clinical and imaging characteristics in patients suffering from pathological myopia. It will involve both retrospective and prospective evaluations, focusing on specific clinical, tomographic, and angiographic variables over a minimum follow-up period of five years. The study does not involve any drug interventions, allowing for a natural observation of the condition's progression.
Why it matters
Potential benefit: If successful, this study could provide valuable insights into the long-term management and understanding of pathological myopia.
How similar studies have gone: While there may be other studies on myopia, this specific observational approach focusing on long-term outcomes is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: \- high myopia Exclusion Criteria: * acute ischemic optic neuropathy * macular and peripapillary atrophy * other forms of maculopathy
Where it's running
-
Istituto Auxologico Italiano IRCCS
Milan, Italy Recruiting
Study contacts
- Study coordinator: Paolo Milani, MD
- Email: dottpaolomilani@hotmail.com
- Phone: +390261911
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Low-level red light to slow retinal thinning in pathologic myopia
This trial will test whether twice-daily low-level red light therapy can slow retinal atrophy in adults with pathologic myopia and is safe to use.
-
See if the Doraldo-Castelletti scale helps decide if migraine patients should see a physiotherapist
This study tests whether a brief cervical screening scale can help neurologists decide which migraine patients might benefit from physiotherapy.
-
MicroRNA and bone markers linked to response to romosozumab and abaloparatide in postmenopausal osteoporosis
Researchers will test whether microRNA and other bone markers can predict how well postmenopausal women with osteoporosis respond to romosozumab and abaloparatide.
-
How obesity affects daily activities and physical abilities in older adults
This study tests how excess weight in people over 65 impacts daily tasks and physical performance, comparing obese seniors to normal-weight peers.
-
Multisensory neuromodulation to improve visual field loss after stroke
This will try combining audio-visual training with noninvasive brain stimulation (tDCS) to help people within three months of stroke who have homonymous hemianopsia improve their visual field and visual scanning.
-
Longitudinal integrated biomarker profiling linked to ALS clinical features
This project will test whether repeated blood and spinal-fluid biomarker measurements combined with deep clinical profiling can help predict disease course in adults with ALS.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.